- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 98,660 | 19.08.24 17:35:57 | +0,210 | +0,21% | 0,000 | 0,000 | 98,270 | 98,450 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.196,880 | 19.08.24 22:00:08 | +17,570 | +1,49% | 1.197,470 | 1.197,920 | 1.180,020 | 1.179,310 |
